• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 8 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 8 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY Back to Search Results
Catalog Number 150610008
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Edema (1820); Pain (1994); Joint Disorder (2373); No Known Impact Or Consequence To Patient (2692); Not Applicable (3189); No Code Available (3191)
Event Date 05/11/2018
Event Type  Injury  
Manufacturer Narrative
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Der states that the patient came in for a revision total knee.Once inside the knee it was determined that the tibial base plate had debonded from the implant.Surgeon removed rotating platform tray and replaced with a stemmable attune fixed bearing implant.Surgeon also put a patella in the patient as it was not resurfaced on the original surgery.There was also loosening of the tibia at the cement to implant interface, unknown cement manufacturer was used.Doi: (b)(6) 2017, dor: (b)(6) 2018, right knee.
 
Manufacturer Narrative
Product complaint #
=
> pc-(b)(4).Investigation summary
=
> no device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint #
=
> (b)(4).Investigation summary
=
> no device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Medical records received on 17 jun 2019 were reviewed to identify patient harms/product issues on 05 november 2019.On (b)(6) 2018, the patient underwent a right knee revision due to loosening of the tibial component, instability, swelling, and pain.The surgeon reported overall gross instability.He indicated evidence of chronic subluxation with some poly wear.The surgeon indicated the tibial component had de-bonded from the cement mantle.He noted the femoral component was in good position, well cemented to the bone, and no evidence of de-bonding or separation.The patella was revised.The surgeon reported no intraoperative complications.The patient was implanted with attune knee system and competitor cement doi: (b)(6) 2017 dor: (b)(6) 2018 (rt knee).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE RP TIB BASE SZ 8 CEM
Type of Device
ATTUNE IMPLANT : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key7574414
MDR Text Key110267889
Report Number1818910-2018-61507
Device Sequence Number1
Product Code NJL
UDI-Device Identifier10603295042624
UDI-Public10603295042624
Combination Product (y/n)N
PMA/PMN Number
P830055
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 05/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2019
Device Catalogue Number150610008
Device Lot Number8410895
Initial Date Manufacturer Received 05/11/2018
Initial Date FDA Received06/06/2018
Supplement Dates Manufacturer Received07/06/2018
11/05/2019
11/05/2019
12/13/2019
Supplement Dates FDA Received07/17/2018
12/02/2019
12/03/2019
12/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATTUNE CR FEM RT SZ 9 CEM; COMPETITOR BONE CEMENT; COMPETITOR BONE CEMENT
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient Weight115
-
-